Table 1 The purifies of TKIs used in the presence work.

From: TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs

TKIs

The purifies from HPLC

sorafenib

99.1 (%)

lenvatinib

99.4

regorafenib

99.2

cabozantinib

99.5

  1. HPLC High-performance liquid chromatography
Back to article page